ESC 365 - Role of natriuretic peptides in the pre-discharge phase

HFA Premium Access

Role of natriuretic peptides in the pre-discharge phase

Session: How to use natriuretic peptides in the management of patients with heart failure

Topic: Heart Failure Association (HFA)

Speaker: Doctor A. Sauer (Kansas City, US)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Andrew Sauer

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

3 presentations

0 follower

4 more presentations in this session

Natriuretic peptides in the diagnosis of heart failure

Speaker: Professor N. Sato (Kawaguchi, JP)

Natriuretic peptides in worsening heart failure

Speaker: Doctor A. Ducharme (Montreal, CA)

Correlation between LVEF and natriuretic peptides

Speaker: Professor R. Doughty (Auckland, NZ)

How to use natriuretic peptides in the management of patients with heart failure - discussion

Access the full session

How to use natriuretic peptides in the management of patients with heart failure

Speakers: Doctor A. Sauer, Professor N. Sato, Doctor A. Ducharme, Professor R. Doughty

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources